approval · primary record
SITAGLIPTIN HYDROCHLORIDE
FDA · NDA · 2025-01-16
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-01-16 |
| Brand | BRYNOVIN |
| Sponsor | AZURITY |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:22.409Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:SITAGLIPTIN HYDROCHLORIDE:2025-01-16
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.